Sabrina Heltz Buys 2,820 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD) Stock

Viemed Healthcare, Inc. (NASDAQ:VMD) Director Sabrina Heltz bought 2,820 shares of the stock in a transaction that occurred on Tuesday, May 14th. The stock was acquired at an average cost of $7.08 per share, for a total transaction of $19,965.60. Following the purchase, the director now owns 41,040 shares of the company’s stock, valued at $290,563.20. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Viemed Healthcare Price Performance

Shares of VMD stock opened at $6.97 on Thursday. Viemed Healthcare, Inc. has a 1 year low of $5.90 and a 1 year high of $10.79. The firm’s 50 day moving average is $8.52 and its 200-day moving average is $8.14. The firm has a market capitalization of $270.58 million, a price-to-earnings ratio of 26.62 and a beta of 1.53. The company has a current ratio of 1.28, a quick ratio of 1.14 and a debt-to-equity ratio of 0.05.

Viemed Healthcare (NASDAQ:VMD) last announced its quarterly earnings data on Wednesday, March 6th. The company reported $0.09 earnings per share for the quarter. Viemed Healthcare had a net margin of 5.32% and a return on equity of 9.32%. The business had revenue of $50.74 million for the quarter.

Hedge Funds Weigh In On Viemed Healthcare

Large investors have recently bought and sold shares of the business. New York State Teachers Retirement System acquired a new position in Viemed Healthcare in the first quarter valued at approximately $29,000. AJOVista LLC bought a new stake in Viemed Healthcare in the fourth quarter valued at approximately $42,000. State Board of Administration of Florida Retirement System bought a new stake in Viemed Healthcare in the third quarter valued at approximately $67,000. Mackenzie Financial Corp bought a new stake in Viemed Healthcare in the third quarter valued at approximately $89,000. Finally, Price T Rowe Associates Inc. MD bought a new stake in Viemed Healthcare in the first quarter valued at approximately $97,000. 74.24% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital upgraded shares of Viemed Healthcare to a “strong-buy” rating in a research report on Tuesday, May 7th.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.